By expenditures
| Name | Title | Type |
|---|---|---|
| Sue Cyncynatus | Chief Financial Officer | Auditee |
| David Andrews | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368110 | 2024 | 2025-09-28 | Rsm US LLP | $2.51M |
| 322823 | 2023 | 2024-09-30 | Rsm US LLP | $3.33M |
| 17363 | 2022 | 2023-09-21 | Rsm US LLP | $5.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 322823 | 2023 | 2024-09-30 | 1076339 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 1076338 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 1076337 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 1076336 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 1076335 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 1076334 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 1076333 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 1076332 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 1076331 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 1076330 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 499897 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 499896 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 499895 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 499894 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 499893 | 2023-003 | Significant Deficiency | - | AB |
| 322823 | 2023 | 2024-09-30 | 499892 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 499891 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 499890 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 499889 | 2023-002 | Significant Deficiency | - | I |
| 322823 | 2023 | 2024-09-30 | 499888 | 2023-002 | Significant Deficiency | - | I |